Clariane : Q2 revenue in line / H1 results towards the high end of the range: a reassuring bias on margins (all countries resilient except France)
>H1 better than forecast, except on net profit - Clariane has published Q2 revenue of € 1,327m (i.e. +4.7% and +6.2%e organic), i.e. € 2,636m at end-June (i.e. +6.1% and +6.8% organic). H1 results were therefore: EBITDA at € 518m, EBIT at € 125m (and net profit IFRS at -€ 52m vs € 1m (-€ 28m vs € 26m pre-IFRS 16). Financial leverage improved by 50bp to 3.6x vs 4.1x at 30 June 2023 (and 3.8x at end-2023). Clariane has confirmed its targets for 2024, i.e. revenue growth...Korian is an actor on the temporary and permanent dependency care market in France, Germany and Italy. Co. offers and develops services related to dependency through its retirement homes (116 as of Dec 31 2009), follow-up care and rehabilitation facilities (35 as of Dec 31 2009) and psychiatric clinics (11 as of Dec 31 2009). Co.'s operations can be divided into four geographical segments: Medical and Social activity in France (retirement homes); Sanitary activity in France (follow-up care, rehabilitation, psychiatry and home medical care); Italy; and Germany.
Oddo Securities provides securities brokerage and research services. The company offers equity, economic, and derivatives research and credit analysis services. It focuses on insurance, automotive, building materials, pharmaceuticals, telecommunications, information technology, and agri-food industries.
Unfortunately, this report is not available for the investor type or country you selected.
Browse all ResearchPool reportsReport is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.